• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hum Vaccin Immunother . The influence of SARS-CoV-2 vaccination on in vitro fertilization outcomes

tetano

Editor, Senior Moderator
Hum Vaccin Immunother


. 2025 Dec;21(1):2541495.
doi: 10.1080/21645515.2025.2541495. Epub 2025 Aug 3. The influence of SARS-CoV-2 vaccination on in vitro fertilization outcomes

Adi Anis Heusler[SUP] 1 2 [/SUP], Amir Weintraub[SUP] 1 2 [/SUP], Diana Stein[SUP] 2 [/SUP], Yael Melamed-Yekel[SUP] 1 2 [/SUP], Sarit Kalfon[SUP] 1 2 [/SUP], Yael Pasternak[SUP] 1 2 [/SUP], David Kulak[SUP] 1 2 [/SUP]



Affiliations
Abstract

In December 2020, the FDA granted emergency use approval for 2 separate mRNA vaccines to combat the COVID-19 pandemic. While many questions as to the long-term safety of the vaccine were raised, this was particularly acute for those patients trying to conceive and among those utilizing assisted reproductive technologies. The study aimed to assess the effect of recent mRNA SARS-CoV-2 vaccination on IVF cycle outcomes. A retrospective case-control study, including all IVF patients under the age of 40 years in a hospital-based practice from January 1 to May 31, 2021. The study group included patients who received two doses of the Pfizer/BioNTech vaccine BNT162b2 SARS-COV-2 vaccine between 7 days to 6 months prior to starting IVF. The control group included unvaccinated patients from the same time period in the same year and in 3 previous years. IVF cycle results were compared between the groups. Three hundred and eighty-five women met the inclusion criteria; 349 in the control group and 36 in the vaccinated group. Demographic and clinical characteristics were comparable between the groups. The pregnancy rate was 33.3% (n = 12) in the vaccinated group vs 31.8% (n = 111) in the control group (p > .1). There were no statistically significant differences between the control and vaccine groups. with a small non-significant trend to higher pregnancy rates in vaccinated patients: pregnancy rate OR for vaccination group was 1.17 (95% CI 0.56-2.44). We observed no influence of mRNA SARS-CoV-2 vaccine on patients' IVF cycle outcomes; vaccination did not change pregnancy rates.

Keywords: COVID-19; Covid vaccine; IVF; fertility; mRNA SARS-COV-2 vaccine.

 
Back
Top Bottom